Idogen AB (Sweden) Investor Sentiment

IDOGEN Stock  SEK 0.12  0.00  0.00%   
About 56% of Idogen AB's investor base is looking to short. The analysis of current outlook of investing in Idogen AB suggests that many traders are alarmed regarding Idogen AB's prospects. The current market sentiment, together with Idogen AB's historical and current headlines, can help investors time the market. In addition, many technical investors use Idogen AB stock news signals to limit their universe of possible portfolio assets.
  
over two months ago at news.google.com         
Hemophilia A Drug Market Size Is Booming Worldwide with Share, Top Key Players - Apiculture Market R...
Google News at Macroaxis
over three months ago at news.google.com         
Idogen European Patent Office intends to grant Idogens patent application - Reuters
Google News at Macroaxis
over six months ago at news.google.com         
Hemophilia A Drug Market Size Is Booming Worldwide with Share, Top Key Players Artrocker - Artrocker
Google News at Macroaxis
over a year ago at news.google.com         
Bids for Idogens technology platform to be submitted no later than July 31 - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Certain Shares of Idogen AB are subject to a Lock-Up Agreement Ending on 12-JUL-2023. - Marketscreen...
Google News at Macroaxis
over a year ago at news.google.com         
Cell Therapy Group Idogen Formally Files for Bankruptcy After Merger Talks Fail - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Idogens Board of Directors proposes that liquidation is not to be resolved at the Annual General Mee...
Google News at Macroaxis
over a year ago at news.google.com         
Idogen working for a sale of its proprietary technology platform - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Global Hemophilia A Drug Market Status and Forecast ... - Scene for Dummies Everything Hollywood Und...
Google News at Macroaxis
over a year ago at news.google.com         
Idogen - Q1 2023 In a tough situation - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
ONCORUS, INC. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard Transfe...
Google News at Macroaxis
over a year ago at news.google.com         
ONCORUS, INC. Change in Directors or Principal Officers - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Idogen in discussions about a reversed merger. The company intends to add an agenda item at the annu...
Google News at Macroaxis
over a year ago at news.google.com         
Swedens Idogen Warns of Liquidation if Capital Plan Fails Shares Plunge 35 percent - Marketscreener....
Google News at Macroaxis
over a year ago at news.google.com         
Idogen is investigating reverse acquisitions to avoid risk of liquidation - Marketscreener.com
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Idogen AB that are available to investors today. That information is available publicly through Idogen media outlets and privately through word of mouth or via Idogen internal channels. However, regardless of the origin, that massive amount of Idogen data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Idogen AB news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Idogen AB relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Idogen AB's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Idogen AB alpha.

Idogen AB Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Idogen Stock analysis

When running Idogen AB's price analysis, check to measure Idogen AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Idogen AB is operating at the current time. Most of Idogen AB's value examination focuses on studying past and present price action to predict the probability of Idogen AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Idogen AB's price. Additionally, you may evaluate how the addition of Idogen AB to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Stocks Directory
Find actively traded stocks across global markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments